In 2013 Marine Drugs started to award an annual price to recognize outstanding papers published in our journal in the area of research, development and production of drugs from the sea, including marine natural product chemistry. We are pleased to announce the second Marine Drugs Best Paper Award for 2014. Nominations were solicited from the Editor-in-Chief and Editorial Board members, with all papers published in 2010 eligible for consideration.
1st prize: Sheila Marie Pimentel-Elardo, Svitlana Kozytska, Tim S. Bugni, Chris M. Ireland, Heidrun Moll and Ute Hentschel
Anti-Parasitic Compounds from Streptomyces sp. Strains Isolated from Mediterranean Sponges
2nd prize: Ruth Harris, Elena Lecumberri and Angeles Heras
Chitosan-Genipin Microspheres for the Controlled Release of Drugs: Clarithromycin, Tramadol and Heparin
1st prize: Leanne Pearson, Troco Mihali, Michelle Moffitt, Ralf Kellmann and Brett Neilan
On the Chemistry, Toxicology and Genetics of the Cyanobacterial Toxins, Microcystin, Nodularin, Saxitoxin and Cylindrospermopsin
For more details, please refer to the Marine Drugs Best Paper Award 2014 Editorial.
Earlier Edition of the Award:
Marine Drugs Best Paper Award 2013
We are pleased to report an increased Impact Factor for Marine Drugs for 2012. According to the newly released 2012 Journal Citation Reports® Science Edition (Thomson Reuters, 2013), the new Impact Factor for Marine Drugs is 3.978. The 5-Year Impact Factor is 3.911. Marine Drugs now ranks 6/59 (Q1) in the category 'Chemistry, Medicinal'.
Evolution of the Marine Drugs Impact Factor since 2006:
Evolution of citations to Marine Drugs since 2006: